Product Details for: Saphnelo

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
300MG/2ML (150MG/ML)
Single-Dose Vial
351(a)
Saphnelo
Rx
Proper Name
anifrolumab-fnia
BLA Number
761123
Applicant
AstraZeneca AB
Original Approval Date
July 30, 2021
Date of First Licensure
RETURN TO SEARCH RESULTS